Active Filter(s):
Details:
Taking a cue from a recently published study, the Cure Parkinson’s Trust along with other organizations, agreed to provide funding to advance the drug into further clinical trials.
Lead Product(s): Ambroxol
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Cure Parkinson’s Trust
Deal Size: $0.6 million Upfront Cash: Undisclosed
Deal Type: Funding February 18, 2020